Patients with severe renal insufficiency (creatinine clearance < 25 mL/min) or severe hepatic insufficiency.
It is advisable to regularly monitor liver function parameters in patients with compensated hepatic insufficiency. As there is currently insufficiency data on administration of L-Alanyl-L-Glutamine to pregnant women, nursing mothers, and children, administration of the preparation in these patient groups is not recommended.